# Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults

> **NCT02296541** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 105 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** DNA Nat-B env
- **BIOLOGICAL:** DNA CON-S env
- **BIOLOGICAL:** DNA Mosaic env
- **BIOLOGICAL:** MVA-CMDR
- **BIOLOGICAL:** Placebo for DNA Nat-B env
- **BIOLOGICAL:** Placebo for DNA CON-S env
- **BIOLOGICAL:** Placebo for DNA Mosaic env
- **BIOLOGICAL:** Placebo for MVA-CMDR

## Key facts

- **NCT ID:** NCT02296541
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-11
- **Final completion:** 2020-07-06
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2023-04-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02296541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02296541, "Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02296541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*